Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.29
Delayed Data
As of Feb 16
 -0.03 / -0.90%
Today’s Change
3.00
Today|||52-Week Range
5.10
-0.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash295.5K632.3K374.5K2.0M
 
 
 
 
 
Short Term Investment Cash-734.6K336.7K-257.8K1.6M
 
 
 
 
 
Cash & Short Term Investments295.5K632.3K374.5K2.0M
 
 
 
 
 
 
ReceivablesReceivables581.0K675.2K278.6K9.7K
 
 
 
 
 
 
InventoriesInventories39.7K88.3K37.6K2.6K
 
 
 
 
 
 
Current AssetsPrepaid Expenses20.3K0.00685.00--
 
 
 
Other Current Assets17.4K----8.2K
 
 
 
Current Assets953.9K1.4M691.4K2.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross550.2K552.2K536.6K538.4K
 
 
 
 
 
Depreciation-537.6K-542.8K-533.2K-536.6K
 
 
 
 
 
Other Assets0.000.0017.4K17.4K
 
 
 
Total Assets966.4K1.4M712.2K2.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.4M1.5M1.8M1.1M
 
 
 
 
 
Accrued Expenses106.0K379.3K201.4K14.3K
 
 
 
 
 
Other Current Liabilities2.7M2.9M201.4K14.3K
 
 
 
 
 
Other Liabilities4.1M4.5M2.3M1.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt400.0K1.3M1.2M1.3M
 
 
 
 
 
Total Liabilities7.0M5.8M3.5M2.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.00--0.00--
Common Equity-6.5M-4.8M-3.2M-641.4K
 
 
 
 
 
Total Shareholder Equity-6.5M-4.8M-3.2M-641.4K
 
 
 
 
 
 
Share InformationCommon Shares Outstanding34.7M35.9M43.0M49.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.